News Story: Full Text
Sponsored By
Cleveland Clinic Brain Tumor and Neuro-Oncology Center
Please Click On The Above Banner For More Details
Braintumor Website

 

Chugai Pharmaceutical`s Antitumor Agent Natulan Now Available for Treating Glioma 28 Feb 2005


Posted on: 02/28/2005

Chugai Pharmaceutical's Antitumor Agent Natulan Now Available for Treating Glioma 28 Feb 2005

Tokyo (JCNN) - Chugai Pharmaceutical (TSE: 4519) has announced that it has received approval for expanded indications of Natulan, an antitumor agent, from the Ministry of Health, Labor and Welfare (Japan).

The newly approved agent is now applicable to the treatment of glioma with malignant astrocytoma and oligodendroglioma.

Developed by F. Hoffmann-La Roche, Natulan, a methylhydrazine compound, has been used in the treatment of malignant lymphoma since 1977.


Click HERE to return to brain tumor news headlines


Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740